MedTrace Logo

Capnographic Monitoring of Propofol-sedation During Colonoscopy

NCT01638793 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 528

Last updated 2013-10-25

No results posted yet for this study

Summary

The present study is a randomized, prospective, single-blinded study. Patients presenting for colonoscopy under sedation will be included according to the statistical sample size calculation. Patients will be randomized to either group 1- capnographic monitoring or group 2- oxygenic monitoring during Propofol-based sedation for colonoscopy. Episodes of Hypoxia are documented and compared in both groups.

Conditions

Interventions

DEVICE

Microcap (Oridion, Needham, MA, USA)

DEVICE

Smart Capno Line Plus O2 (Oridion, Needham, MA, USA)

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Mireen Friedrich-Rust, MD · Klinikum der J. W. Goethe-Universität Frankfurt am Main

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01638793 on ClinicalTrials.gov